CAPROCK Group Inc. lowered its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 1.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,714 shares of the healthcare conglomerate’s stock after selling 117 shares during the period. CAPROCK Group Inc.’s holdings in UnitedHealth Group were worth $1,922,000 at the end of the most recent reporting period.
A number of other large investors have also bought and sold shares of UNH. Capital International Investors boosted its stake in UnitedHealth Group by 223.0% during the third quarter. Capital International Investors now owns 16,319,843 shares of the healthcare conglomerate’s stock worth $4,341,731,000 after acquiring an additional 11,267,910 shares in the last quarter. FMR LLC lifted its stake in shares of UnitedHealth Group by 5.1% in the second quarter. FMR LLC now owns 61,622,355 shares of the healthcare conglomerate’s stock worth $15,118,428,000 after buying an additional 2,981,233 shares in the last quarter. Rehmann Capital Advisory Group lifted its stake in shares of UnitedHealth Group by 26,088.2% in the third quarter. Rehmann Capital Advisory Group now owns 1,723,185 shares of the healthcare conglomerate’s stock worth $6,477,000 after buying an additional 1,716,605 shares in the last quarter. Vanguard Group Inc lifted its stake in shares of UnitedHealth Group by 1.6% in the third quarter. Vanguard Group Inc now owns 69,342,549 shares of the healthcare conglomerate’s stock worth $18,447,892,000 after buying an additional 1,073,505 shares in the last quarter. Finally, Vanguard Group Inc. lifted its stake in shares of UnitedHealth Group by 1.6% in the third quarter. Vanguard Group Inc. now owns 69,342,549 shares of the healthcare conglomerate’s stock worth $18,447,892,000 after buying an additional 1,073,505 shares in the last quarter. 85.31% of the stock is currently owned by institutional investors and hedge funds.
In related news, Director Richard T. Burke sold 15,000 shares of the stock in a transaction that occurred on Thursday, January 17th. The shares were sold at an average price of $260.55, for a total transaction of $3,908,250.00. Following the transaction, the director now owns 193,872 shares in the company, valued at $50,513,349.60. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction that occurred on Tuesday, January 22nd. The shares were sold at an average price of $266.61, for a total transaction of $1,333,050.00. Following the transaction, the director now owns 77,702 shares in the company, valued at approximately $20,716,130.22. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 26,090 shares of company stock worth $6,956,975. 0.87% of the stock is owned by insiders.
Shares of UnitedHealth Group stock opened at $261.90 on Monday. The company has a market cap of $251.96 billion, a P/E ratio of 20.33, a P/E/G ratio of 1.34 and a beta of 0.86. UnitedHealth Group Inc has a twelve month low of $212.01 and a twelve month high of $287.94. The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.69 and a current ratio of 0.73.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, January 15th. The healthcare conglomerate reported $3.28 earnings per share for the quarter, beating the Zacks’ consensus estimate of $3.20 by $0.08. The company had revenue of $58.42 billion for the quarter, compared to the consensus estimate of $58.01 billion. UnitedHealth Group had a net margin of 5.30% and a return on equity of 24.38%. The firm’s revenue for the quarter was up 12.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.59 earnings per share. On average, research analysts anticipate that UnitedHealth Group Inc will post 14.62 earnings per share for the current fiscal year.
WARNING: This piece of content was reported by Community Financial News and is owned by of Community Financial News. If you are viewing this piece of content on another site, it was illegally copied and reposted in violation of US and international copyright & trademark law. The legal version of this piece of content can be read at https://www.com-unik.info/2019/02/11/caprock-group-inc-reduces-position-in-unitedhealth-group-inc-unh.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
See Also: Should You Consider an Index Fund?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.